Orchestra BioMed Holdings, Inc. (OBIO)

NASDAQ: OBIO · Real-Time Price · USD

4.400

-0.280 (-5.98%)

At close: Dec 5, 2025, 4:00 PM EST

4.470

+0.070 (1.59%)

After-hours: Dec 5, 2025, 4:47 PM EST

Orchestra BioMed Holdings Employees

Orchestra BioMed Holdings had 70 employees as of December 31, 2024. The number of employees increased by 14 or 25.00% compared to the previous year.

Employees

70

Change (1Y)

14

Growth (1Y)

25.00%

Revenue / Employee

$40,257

Profits / Employee

-$1,072,871

Market Cap

248.44M

Employees Chart

Employees History

Date	Employees	Change	Growth
Dec 31, 2024	70	14	25.00%
Dec 31, 2023	56	-	-

Related Stocks

Company Name	Employees
UnitedHealth Group	400,000
Johnson & Johnson	138,100
Thermo Fisher Scientific	125,000
Abbott Laboratories	114,000
AstraZeneca	92,900
Novo Nordisk	77,349
Novartis AG	75,883
Merck & Co.	75,000

Employee Rankings

OBIO News

9 days ago - Orchestra BioMed Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
25 days ago - Orchestra BioMed to Participate in Upcoming Institutional Investor Conferences - GlobeNewsWire
25 days ago - Orchestra BioMed Reports Third Quarter 2025 Financial Results and Highlights Recent Business Updates - GlobeNewsWire
4 weeks ago - Orchestra BioMed to Host Business Update Call on November 12, 2025 - GlobeNewsWire
5 weeks ago - Orchestra BioMed and Terumo Enter into New $30 Million Virtue SAB Strategic Agreements - GlobeNewsWire
5 weeks ago - Orchestra BioMed Announces First Patients Enrolled in Virtue® SAB US Pivotal IDE Coronary Trial - GlobeNewsWire
2 months ago - Orchestra BioMed to Showcase Transformative Potential of AVIM Therapy in Keynote Presentation on Hypertensive Heart Disease at Georgia Innovation Summit - GlobeNewsWire
3 months ago - Orchestra BioMed Presents New AVIM Therapy Clinical Data at HRX Demonstrating Substantial and Sustained Blood Pressure Reductions that are Reproducible Upon Reactivation Following Washout - GlobeNewsWire